{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T15:49:37Z","timestamp":1789487377956,"version":"build-2803163510"},"reference-count":62,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"unspecified","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81874086"],"award-info":[{"award-number":["81874086"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001692"],"award-info":[{"award-number":["82001692"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072797"],"award-info":[{"award-number":["82072797"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2026,8,31]]},"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Gliomas are resistant to current therapies, and natural killer (NK) cell-based immunotherapy shows limited efficacy. Gasdermin E (GSDME)-mediated pyroptosis contributes to NK-induced tumor killing, but NK cell dysfunction in the glioma microenvironment remains poorly understood. This study investigates whether leucine-rich repeats and immunoglobulin-like domains 2 (LRIG2) enable glioma cells to evade NK-induced pyroptosis and elucidates the underlying mechanism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used in vitro co-culture systems with glioma cell lines (LN229, HS683, FU) and primary NK cells or NK92-MI cells to assess cytotoxicity, pyroptosis (lactate dehydrogenase release, morphology, GSDME cleavage by western blot), and cytokine release (Cytometric Bead Array). In vivo, orthotopic glioma models in C57BL\/6 and RAG1-KO mice received intracranial stimulator of interferon genes agonist diABZI. Mechanistic dissection involved biochemical approaches (co-immunoprecipitation-mass spectrometry and membrane protein extraction), cellular imaging (immunofluorescence), and genetic perturbation via CRISPR-mediated knockdown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>NK cells induced GSDME-dependent pyroptosis in glioma cells in vitro, but this was impaired in vivo due to suppressed NK cytotoxicity. LRIG2 was highly expressed in gliomas; its overexpression inhibited GSDME cleavage, pyroptosis, and glioma cell death, whereas LRIG2 knockdown enhanced these effects. Mechanistically, soluble LRIG2 shed from glioma cells bound to lysosomal-associated membrane protein 1 (LAMP1) on NK cells, upregulating phosphorylated-signal transducer and activator of transcription (p-STAT3) via Janus kinase 1 (JAK1) and reducing granzyme B and perforin release. Disrupting the LRIG2\u2013LAMP1\u2013STAT3 axis by LRIG2 knockdown or STAT3 knockout restored NK cytotoxicity and GSDME cleavage. Combining LRIG2 knockdown with diABZI significantly enhanced NK granzyme B expression and prolonged mouse survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>LRIG2 enables glioma immune evasion by suppressing NK-induced GSDME-mediated pyroptosis via the LAMP1\u2013STAT3 pathway. Targeting this axis represents a promising strategy to enhance NK cell-based immunotherapy for gliomas, positioning LRIG2 as a potential biomarker and therapeutic target.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2026-015730","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T14:01:02Z","timestamp":1789480862000},"page":"e015730","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["LRIG2 suppresses NK cell-induced GSDME-mediated pyroptosis via the LAMP1-STAT3 pathway in glioma"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-3363-7692","authenticated-orcid":false,"given":"Xiaoshuang","family":"Hou","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Lin","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology\uff0cChinese Academy of Sciences, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Union Hospital, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youwei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pain Management, Southeast University, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minhai","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sui","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohu","family":"Oyang","sequence":"additional","affiliation":[{"name":"Department of Integrated Traditional Chinese and Western Medicine, Union Hospital, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingbo","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Integrated Traditional Chinese and Western Medicine, Union Hospital, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangling","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Mao","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingjiang","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology, College of Basic Medicine, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desheng","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Integrated Traditional Chinese and Western Medicine, Union Hospital, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baofeng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"2026091507004512000_14.9.e015730.1","doi-asserted-by":"crossref","DOI":"10.1126\/science.adt0559","article-title":"IDH-mutant gliomas arise from glial progenitor cells harboring the initial driver mutation","volume":"391","author":"Park","year":"2026","journal-title":"Science"},{"key":"2026091507004512000_14.9.e015730.2","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-025-02299-4","article-title":"Glioblastoma at the crossroads: current understanding and future therapeutic horizons","volume":"10","author":"Singh","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"2026091507004512000_14.9.e015730.3","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-1474"},{"key":"2026091507004512000_14.9.e015730.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.12.015"},{"key":"2026091507004512000_14.9.e015730.5","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noaf194"},{"key":"2026091507004512000_14.9.e015730.6","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012532","article-title":"IL-12-secreting CAR-T cells reprogram the tumor microenvironment and improve efficacy against heterogeneous models of glioblastoma","volume":"14","author":"Shen","year":"2026","journal-title":"J Immunother Cancer"},{"key":"2026091507004512000_14.9.e015730.7","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-024-01544-7","article-title":"Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives","volume":"17","author":"Lin","year":"2024","journal-title":"J Hematol Oncol"},{"key":"2026091507004512000_14.9.e015730.8","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1158\/2326-6066.CIR-24-0807","article-title":"The TRIB2-DNMT1 Pathway Generates an Immune-Cold Microenvironment in Glioblastoma, and Its Inhibition Promotes Immunotherapy","volume":"13","author":"Segura-Collar","year":"2025","journal-title":"Cancer Immunol Res"},{"key":"2026091507004512000_14.9.e015730.9","doi-asserted-by":"crossref","DOI":"10.1186\/s40164-023-00464-5","article-title":"The role of pyroptosis and gasdermin family in tumor progression and immune microenvironment","volume":"12","author":"Li","year":"2023","journal-title":"Exp Hematol Oncol"},{"key":"2026091507004512000_14.9.e015730.10","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2071-9"},{"key":"2026091507004512000_14.9.e015730.11","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaz7548","article-title":"Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells","volume":"368","author":"Zhou","year":"2020","journal-title":"Science"},{"key":"2026091507004512000_14.9.e015730.12","first-page":"1069","article-title":"LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFR\u03b2 signaling","volume":"53","author":"Xiao","year":"2018","journal-title":"Int J Oncol"},{"key":"2026091507004512000_14.9.e015730.13","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/s41417-020-0163-1","article-title":"Targeting LRIG2 overcomes resistance to EGFR inhibitor in glioblastoma by modulating GAS6\/AXL\/SRC signaling","volume":"27","author":"Dong","year":"2020","journal-title":"Cancer Gene Ther"},{"key":"2026091507004512000_14.9.e015730.14","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00447","article-title":"The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma","volume":"9","author":"Cheng","year":"2019","journal-title":"Front Oncol"},{"key":"2026091507004512000_14.9.e015730.15","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-006-0032-5"},{"key":"2026091507004512000_14.9.e015730.16","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004452","article-title":"LRIG2 promotes glioblastoma progression by modulating innate antitumor immunity through macrophage infiltration and polarization","volume":"10","author":"Hu","year":"2022","journal-title":"J Immunother Cancer"},{"key":"2026091507004512000_14.9.e015730.17","doi-asserted-by":"crossref","unstructured":"Li Y , Wang W , Hou X , et al . Glioma-derived LRIG3 interacts with NETO2 in tumor-associated macrophages to modulate microenvironment and suppress tumor growth. Cell Death Dis 2023;14. doi:10.1038\/s41419-023-05555-z","DOI":"10.1038\/s41419-023-05555-z"},{"key":"2026091507004512000_14.9.e015730.18","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2022.5429","article-title":"Establishment and characteristics of GWH04, a new primary human glioblastoma cell line","volume":"61","author":"Cheng","year":"2022","journal-title":"Int J Oncol"},{"key":"2026091507004512000_14.9.e015730.19","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3892\/ijo.2013.1776","article-title":"A role for LRIG1 in the regulation of malignant glioma aggressiveness","volume":"42","author":"Mao","year":"2013","journal-title":"Int J Oncol"},{"key":"2026091507004512000_14.9.e015730.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2017.10.005"},{"key":"2026091507004512000_14.9.e015730.21","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae973"},{"key":"2026091507004512000_14.9.e015730.22","doi-asserted-by":"crossref","DOI":"10.1038\/s41421-022-00387-1","article-title":"Cell-in-cell structure mediates in-cell killing suppressed by CD44","volume":"8","author":"Su","year":"2022","journal-title":"Cell Discov"},{"key":"2026091507004512000_14.9.e015730.23","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00154-z"},{"key":"2026091507004512000_14.9.e015730.24","doi-asserted-by":"crossref","unstructured":"Wang L , Liang Z , Guo Y , et al . STING agonist diABZI enhances the cytotoxicity of T cell towards cancer cells. Cell Death Dis 2024;15. doi:10.1038\/s41419-024-06638-1","DOI":"10.1038\/s41419-024-06638-1"},{"key":"2026091507004512000_14.9.e015730.25","doi-asserted-by":"crossref","unstructured":"Wang Q , Yu Y , Zhuang J , et al . Demystifying the cGAS-STING pathway: precision regulation in the tumor immune microenvironment. Mol Cancer 2025;24. doi:10.1186\/s12943-025-02380-0","DOI":"10.1186\/s12943-025-02380-0"},{"key":"2026091507004512000_14.9.e015730.26","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03152-x"},{"key":"2026091507004512000_14.9.e015730.27","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0705-y"},{"key":"2026091507004512000_14.9.e015730.28","doi-asserted-by":"crossref","first-page":"113108","DOI":"10.1016\/j.celrep.2023.113108","article-title":"STING signaling promotes NK cell antitumor immunity and maintains a reservoir of TCF-1+ NK cells","volume":"42","author":"Lu","year":"2023","journal-title":"Cell Rep"},{"key":"2026091507004512000_14.9.e015730.29","doi-asserted-by":"crossref","first-page":"11441","DOI":"10.3390\/ijms262311441","article-title":"STING Restricts EV-A71 Infection by Regulating T Cell Development and Enhancing Immune Cell Effector Function","volume":"26","author":"Wang","year":"2025","journal-title":"IJMS"},{"key":"2026091507004512000_14.9.e015730.30","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/931562","article-title":"Inflammatory mediator profiling reveals immune properties of chemotactic gradients and macrophage mediator production inhibition during thioglycollate elicited peritoneal inflammation","volume":"2013","author":"Lam","year":"2013","journal-title":"Mediators Inflamm"},{"key":"2026091507004512000_14.9.e015730.31","doi-asserted-by":"crossref","DOI":"10.1038\/s41389-017-0012-8","article-title":"Lrig1 is a haploinsufficient tumor suppressor gene in malignant glioma","volume":"7","author":"Mao","year":"2018","journal-title":"Oncogenesis"},{"key":"2026091507004512000_14.9.e015730.32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jns.2015.02.015","article-title":"LRIG3 modulates proliferation, apoptosis and invasion of glioblastoma cells as a potent tumor suppressor","volume":"350","author":"Guo","year":"2015","journal-title":"J Neurol Sci"},{"key":"2026091507004512000_14.9.e015730.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2004.08.008"},{"key":"2026091507004512000_14.9.e015730.34","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01462-9"},{"key":"2026091507004512000_14.9.e015730.35","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1021\/acsbiomaterials.3c01617","article-title":"Nanofibrous MultiDomain Peptide Hydrogels Provide T Cells a 3D, Cytocompatible Environment for Cell Expansion and Antigen-Specific Killing","volume":"10","author":"Leyva-Aranda","year":"2024","journal-title":"ACS Biomater Sci Eng"},{"key":"2026091507004512000_14.9.e015730.36","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-08-453738"},{"key":"2026091507004512000_14.9.e015730.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2021.09.027"},{"key":"2026091507004512000_14.9.e015730.38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164593","article-title":"Identification of Putative Receptors for the Novel Adipokine CTRP3 Using Ligand-Receptor Capture Technology","volume":"11","author":"Li","year":"2016","journal-title":"PLoS ONE"},{"key":"2026091507004512000_14.9.e015730.39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02456","article-title":"Transcriptional, Epigenetic and Pharmacological Control of JAK\/STAT Pathway in NK Cells","volume":"10","author":"Scarno","year":"2019","journal-title":"Front Immunol"},{"key":"2026091507004512000_14.9.e015730.40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02590","article-title":"JAK\/STAT Cytokine Signaling at the Crossroad of NK Cell Development and Maturation","volume":"10","author":"Gotthardt","year":"2019","journal-title":"Front Immunol"},{"key":"2026091507004512000_14.9.e015730.41","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-03-564450"},{"key":"2026091507004512000_14.9.e015730.42","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2018.8"},{"key":"2026091507004512000_14.9.e015730.43","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1998.71051837.x"},{"key":"2026091507004512000_14.9.e015730.44","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cytogfr.2025.01.003","article-title":"Insights into IL-6\/JAK\/STAT3 signaling in the tumor microenvironment: Implications for cancer therapy","volume":"85","author":"Thuya","year":"2025","journal-title":"Cytokine Growth Factor Rev"},{"key":"2026091507004512000_14.9.e015730.45","doi-asserted-by":"crossref","unstructured":"Wang Y , Guo Z , Xu A , et al . Mechanistic insights into IL-6-mediated NK cell dysfunction in NSCLC via the IRE1\u03b1-XBP1s-STAT3-UBE2S axis. npj Precis Onc 2025;9. doi:10.1038\/s41698-025-01140-z","DOI":"10.1038\/s41698-025-01140-z"},{"key":"2026091507004512000_14.9.e015730.46","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-019-1310-0","article-title":"IL-6 and IL-8 secreted by tumour cells impair the function of NK cells via the STAT3 pathway in oesophageal squamous cell carcinoma","volume":"38","author":"Wu","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"2026091507004512000_14.9.e015730.47","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(92)90030-G"},{"key":"2026091507004512000_14.9.e015730.48","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-025-02344-4","article-title":"Targeting pyroptosis for cancer immunotherapy: mechanistic insights and clinical perspectives","volume":"24","author":"Huang","year":"2025","journal-title":"Mol Cancer"},{"key":"2026091507004512000_14.9.e015730.49","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-024-03467-2","article-title":"Comprehensive analysis, diagnosis, prognosis, and cordycepin (CD) regulations for GSDME expressions in pan-cancers","volume":"24","author":"Fu","year":"2024","journal-title":"Cancer Cell Int"},{"key":"2026091507004512000_14.9.e015730.50","doi-asserted-by":"crossref","DOI":"10.1038\/s41698-023-00356-1","article-title":"Advances in NK cell therapy for brain tumors","volume":"7","author":"Fares","year":"2023","journal-title":"NPJ Precis Oncol"},{"key":"2026091507004512000_14.9.e015730.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.11.032"},{"key":"2026091507004512000_14.9.e015730.52","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-32311-2","article-title":"Circular EZH2-encoded EZH2-92aa mediates immune evasion in glioblastoma via inhibition of surface NKG2D ligands","volume":"13","author":"Zhong","year":"2022","journal-title":"Nat Commun"},{"key":"2026091507004512000_14.9.e015730.53","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142116","article-title":"Targeting the \u03b1v integrin\/TGF-\u03b2 axis improves natural killer cell function against glioblastoma stem cells","volume":"131","author":"Shaim","year":"2021","journal-title":"J Clin Invest"},{"key":"2026091507004512000_14.9.e015730.54","doi-asserted-by":"crossref","unstructured":"Deng Y , Liu J , Pu Z , et al . Targeting the HLA-E\u2013NKG2A axis in combination with MS-275 enhances NK cell-based immunotherapy against DMG. J Exp Clin Cancer Res 2025;44. doi:10.1186\/s13046-025-03390-y","DOI":"10.1186\/s13046-025-03390-y"},{"key":"2026091507004512000_14.9.e015730.55","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27052457","article-title":"Heat up and Destroy: Immunotherapy of \u201cCold\u201d Tumors Using the Example of Glioblastoma","volume":"27","author":"Nikitina","year":"2026","journal-title":"Int J Mol Sci"},{"key":"2026091507004512000_14.9.e015730.56","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.947568","article-title":"The Multifaceted Role of STAT3 in NK-Cell Tumor Surveillance","volume":"13","author":"Witalisz-Siepracka","year":"2022","journal-title":"Front Immunol"},{"key":"2026091507004512000_14.9.e015730.57","doi-asserted-by":"crossref","first-page":"217601","DOI":"10.1016\/j.canlet.2025.217601","article-title":"Advancing glioblastoma therapy: Learning from the past and innovations for the future","volume":"617","author":"Rana","year":"2025","journal-title":"Cancer Lett"},{"key":"2026091507004512000_14.9.e015730.58","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1661327","article-title":"Targeting the neuroimmune axis in glioblastoma: emerging strategies for precision immunotherapy","volume":"16","author":"Lang","year":"2025","journal-title":"Front Immunol"},{"key":"2026091507004512000_14.9.e015730.59","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05680-3"},{"key":"2026091507004512000_14.9.e015730.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.05.007"},{"key":"2026091507004512000_14.9.e015730.61","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1681966","article-title":"Shaping the glioblastoma microenvironment to enhance CAR-NK immunotherapy","volume":"16","author":"Tang","year":"2025","journal-title":"Front Immunol"},{"key":"2026091507004512000_14.9.e015730.62","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/s41416-025-02977-8","article-title":"CAR-NK cell therapy combined with checkpoint inhibition induces an NKT cell response in glioblastoma","volume":"132","author":"Strassheimer","year":"2025","journal-title":"Br J Cancer"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2026-015730","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T14:01:11Z","timestamp":1789480871000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2026-015730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":62,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,15]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1136\/jitc-2026-015730"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2026-015730","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}